Stock Analysis
International Business Machines Corporation (IBM)
NYSE: IBM · IT Services, Software and Infrastructure
Updated
Rated Watchlist, with a fair value of $250.21 against a last close of $251.46 (-0.5% implied upside). IBM's third quarter answered the deferred-deal question, with about two-thirds of the slipped deals closed and Software narrowed to about 7-8%, but the shares rose 11.5% into the release and sat at the $250 weighted fair value, so Watchlist holds and the buy zone moves up to $220-$230.
- Verdict
- Watchlist
- Fair Value
- $250.21
- Investment Score
- 66.5/100prev 66.4
Technical read (chart only): Conflicts as of Before the results the shares closed back at the 200-day average with the 50-day rising, a turn ahead of the fundamentals; watch whether the 200-day holds after the release, while a fall toward the 50-day near $232 would bring the $220-$230 zone into view.The Watchlist verdict comes from the fundamentals alone. The technical read looks only at the price chart. It does not change the verdict or the score and only guides entry timing.
Investment Scorecard
Composite score 66.5/100 (previous 66.4). Every factor is scored out of 10, ten always being the best outcome, including for risk.
| Factor | Score | Weight | Change | Basis |
|---|---|---|---|---|
| Business Quality | 7/10 | 15% | unchanged | Two wide moats (IBM Z, Red Hat) and two adequate ones; the quarter tested none of them. |
| Financial Strength | 8/10 | 15% | unchanged | Free cash flow guidance raised; debt up $2.6bn this year to $63.8bn after $11.4bn of acquisitions. |
| Competitive Advantage | 8/10 | 15% | unchanged | Red Hat bookings back to high-teens growth and Data up 19%; no change in position. |
| Management | 7/10 | 10% | +1 vs last report | About two-thirds of the slipped deals closed within one quarter, ahead of the six months guided; long-term targets deferred to January. |
| Growth Potential | 6/10 | 15% | unchanged | Software narrowed to about 7-8%, but group revenue guidance is still 4-5% and transaction processing is guided flat. |
| Valuation | 5/10 | 20% | -1 vs last report | The shares ran 11.5% into the print; 19.1x 2027 consensus and a weighted value within 1% of the price. |
| Risk (10 = lowest risk) | 6/10 | 10% | +1 vs last report | The deferred-deal question is largely answered; cycle, discount-rate and leverage risks remain. |
Recent Developments
| Date | Development | Impact |
|---|---|---|
| January 2027 update on 2027 and long-term targets Management deferred 2027 and the double-digit Software target to its January update; date not yet announced, late January is the usual pattern. Reading: The dated event the bull case depends on. | Medium | |
| Software guidance narrowed; slipped deals closed About two-thirds of the large deals that slipped from Q2 closed in Q3; Software guided to about 7-8% for 2026 (from 6-8%), base about 7%; free cash flow guided up more than $1bn (from about $1bn). Reading: Answers the question behind the last three reports, but at the middle of the old range rather than the high end. | Medium | |
| Confluent Streamhouse New data-streaming offering on the Confluent platform introduced; Data grew 19% in Q3. Management expects 2027 growth synergies. Reading: Evidence the Confluent purchase is adding growth; synergies remain a forecast. | Medium | |
| DARPA Quantum Benchmarking Initiative, Stage C IBM advanced to the hardware-testing stage; no funding amount disclosed. IBM expects a first fault-tolerant system in 2029. Reading: Supports the quantum roadmap and the bull narrative; no revenue inside two years. | Medium | |
| Anderon quantum wafer foundry $1bn CHIPS award plus $1bn of IBM investment; no revenue, capacity or customers disclosed since. Quantum Day is on 10 December. Reading: Rated Medium from High: the commitment is modest against about $14.4bn of trailing free cash flow and has no revenue path in the horizon. | Medium | |
| IBM Ready for SAP Solutions Cloud ERP modernisation offering for midsize firms, limited countries; no pricing. Reading: Small Consulting pull; immaterial. | Low |
Key Risks
| Risk | Probability | Severity | Comment |
|---|---|---|---|
| Discount rate | High | Medium | Ten-year at 5.13%, 2.44 points above the 2.69% dividend yield; the Fed meets 27-28 October. |
| A catch-up quarter | Medium | Medium | About a quarter of Software's acceleration came from deals that slipped from Q2. |
| IBM Z and transaction processing | Medium | Medium | Z fell 20%; transaction processing guided flat for the year and to moderate in Q4. |
| Valuation after the run | Medium | Medium | 19.1x 2027 consensus against 17.7x forward three weeks earlier. |
| Leverage and acquisitions | Low | Medium | Debt $63.8bn; $11.4bn spent on acquisitions this year; cash down $3.4bn. |
| Securities-fraud investigations | Low | Medium | Law firms still investigating the July warning; no complaint filed. |
| Consulting stagnation | Medium | Low | Revenue flat in dollars; margin fell to 12.2%. |
| Quantum execution | Medium | Low | $2bn committed to the foundry with no revenue, capacity or customers disclosed. |
Scenario Analysis
| Case | Probability | Fair Value | Outlook |
|---|---|---|---|
| Bull | 30% | $291.90 | Software reaches double digits in Q4 and high single digits or better in 2027, Red Hat stays at double digits, the remaining slipped deals close and the January framework restates the double-digit target; 2027 EPS $13.90 at 21.0x. |
| Base | 52% | $246.05 | Software near 7% for 2026 and 7-8% in 2027, transaction processing flat as guided, Consulting low single digits, free cash flow up a little over $1bn; 2027 EPS $13.30 at 18.5x. |
| Bear | 18% | $192.75 | The third quarter proves a catch-up, transaction processing declines in 2027 as the z17 cycle ages, Consulting stalls and the January targets disappoint; 2027 EPS $12.85 at 15.0x. |
The Case
Would new money go into IBM today? Not at $251.46, a close set before the results were released. The quarter answered the question this coverage has asked since July: about two-thirds of the slipped deals closed, Software grew 8.7% at constant currency and was narrowed to about 7-8% for the year, and free cash flow guidance went up.
The biggest concern is now the price, which rose 11.5% in the three weeks before the release to sit at the $250.21 weighted fair value, 19.1 times 2027 earnings for a company guiding 4-5% revenue growth. The view improves at $220-$230, or with a fourth quarter showing Software near double digits and a January framework that keeps the double-digit target. No company development drove the answer.
Archived Reports
Beating The Bull keeps every past version of this report on file. Verdicts and numbers reflect what was known when each one was published.
Informational use only. Not financial advice.